Speech by the Chief Administrative Secretary, Dr Rashid Aman, During the Launch of The Mobile Pharmacovigilance Electronic Reporting System (Mpvers)

ppb_admin — Wed, 13 Apr 2022 08:28:05 +0000

Good Morning Ladies and Gentlemen,

It is my pleasure to be here today as we launch the Mobile Pharmacovigilance Electronic Reporting System (mPvERS). This is another great milestone achieved by the Pharmacy and Poisons Board towards the monitoring of quality, safety and efficacy of health products and technologies in Kenya.

As you are aware, the Pharmacy and Poisons Board is the Regional Centre of Regulatory Excellence (RCORE) in Pharmacovigilance. Therefore, it plays a key role in the African Medicines Regulatory Harmonisation Programme by the African Union Development Agency-NEPAD (AUDA- NEPAD). Other bodies include the East African Community (EAC), and the Intergovernmental Authority on Development (IGAD) medicines regulation harmonization initiatives.

Ladies and Gentlemen,

The public is increasingly becoming aware of health-related matters including disease conditions, disease management and adverse events following the use of health products and technologies. Patients are able to provide detailed first- hand information about their experiences with medicines, and how these medicines have affected their life.

This includes reports of adverse events for “over the counter” (OTC) medicines, herbal medicines, vaccines and reports on suspected poor quality health products and technologies.

Consumer reporting is therefore a useful tool in empowering the consumers, and improving their involvement in the management of their own health. In this regard, the Pharmacy and Poisons Board through the support from the USAID Medicines, Technologies and Pharmaceutical Services (MTaPS) Program has developed a mobile pharmacovigilance electronic reporting system (mPvERS).

This is a mobile based solution that provides for reporting on both Android and iOS operating system, as well as an Unstructured Supplementary Service Data (USSD) platform. Through the USSD code, the public will be able to report on adverse events following the use of medicines, vaccines and medical devices. In addition, they shall be able to report on poor quality health products and technologies.

The solution is developed to supplement the existing national reporting system PvERS II, which was launched in March 2021 to enhance consumer reporting.

Ladies and Gentlemen,

The Ministry of Health through Pharmacy and Poisons Board is committed to providing Kenyans with safe, quality and efficacious health products and health technologies. We are therefore looking forward to great outputs from these innovative solutions.

Finally, I urge you all to support this initiative as we strive to protect health and safety of the public by ensuring quality, safety and efficacy of health products and technologies circulating in Kenya.

It is now my great pleasure to declare the mPvERS system officially launched.

I thank you all.

Dr Rashid Aman
Chief Administrative Secretary.

The post Speech by the Chief Administrative Secretary, Dr Rashid Aman, During the Launch of The Mobile Pharmacovigilance Electronic Reporting System (Mpvers) first appeared on Pharmacy and Poisons Board.

Talking Points by PPB Chief Executive Officer, Dr F. M. Siyoi during the launch of the Mobile Pharmacovigilance Electronic Reporting System (Mpvers) on 13th April 2022

ppb_admin — Wed, 13 Apr 2022 08:25:59 +0000

Good Morning Ladies and Gentlemen,

It is my pleasure to welcome you all to witness another milestone by the Pharmacy and Poisons Board in protecting public health and promoting patient safety.

As you are aware, the Pharmacovigilance electronic reporting system (PvERS) has been in operation since the year 2013. In order to align with the international standards and cognizant of the expanded scope of pharmacovigilance globally, the PvERS was upgraded to PvERS II in March, 2021 to include reporting of adverse events following immunization, medication errors, transfusion reactions and incidents from medical devices. The PPB has received over 16,000 reports which have been used to inform policy change, review of treatment guidelines and various regulatory actions.

In this regard, the PPB through immense support from the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program has developed a mPvERs system; a mobile based solution that provides a reporting platform of adverse reactions and suspected poor quality health products and technologies by the public. This will go a long way in strengthening reporting and

Page 1 of 2

vigilance on safety quality issues for health products and technologies in Kenya both by healthcare providers and the general public.

I sincerely thank the USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, for their technical and financial support in the development of the mPvERs platform. Thank you each one of us for taking time off your busy schedules to attend this important function. We are always grateful for your support and collaboration.

As I conclude Ladies and Gentlemen, I have the pleasure to welcome our Chief Guest, the Chief Administrative Secretary, Ministry of Health; Dr. Rashid Aman to make his remarks and officially launch the platform.

Asanteni Sana

The post Talking Points by PPB Chief Executive Officer, Dr F. M. Siyoi during the launch of the Mobile Pharmacovigilance Electronic Reporting System (Mpvers) on 13th April 2022 first appeared on Pharmacy and Poisons Board.

Speech - Pharmacy and Poisons Board

Speech by the Chief Administrative Secretary, Dr Rashid Aman, During the Launch of The Mobile Pharmacovigilance Electronic Reporting System (Mpvers)

Talking Points by PPB Chief Executive Officer, Dr F. M. Siyoi during the launch of the Mobile Pharmacovigilance Electronic Reporting System (Mpvers) on 13th April 2022